How Steroid Profiling Uses Longitudinal Markers

Testosterone and related compounds occur naturally, so finding them in a sample proves nothing. Detection relies instead on comparing an athlete with his own previous measurements.

Population thresholds fail on natural variation

Hormone concentrations differ widely between individuals for genetic and physiological reasons, so a single universal cut-off would catch some clean athletes and miss others entirely.

Setting the threshold high enough to avoid false findings leaves a wide margin in which use is undetectable. That margin is exactly where micro-dosing operates.

The problem is not analytical sensitivity. Laboratories can measure precisely; the difficulty is knowing what a given result means for a given person.

A personal baseline replaces the population figure

Repeated samples build a profile of an athlete's typical ratios between related steroid metabolites, which are far more stable within a person than between people.

Statistical modelling then produces an expected range for that individual, and each new sample is assessed against it rather than against a population value.

A result inside the population range but well outside the personal range becomes a signal, which is the sensitivity that population testing lacked.

Confounders must be excluded before conclusions

Alcohol, some medications, bacterial degradation of a sample and genetic variants in metabolising enzymes all shift the measured ratios.

Certain genetic profiles produce naturally unusual excretion patterns, and where those are present the standard markers must be interpreted differently.

Expert panels therefore review flagged profiles rather than treating a deviation as a finding, and they may request further targeted testing.

Isotope ratio analysis provides the confirmation

Synthetic steroids are manufactured from plant sterols and carry a slightly different carbon isotope signature from hormones the body produced.

Measuring that ratio can distinguish endogenous from administered compounds, converting a statistical anomaly into direct evidence.

The technique is expensive and slower than routine screening, so it is applied selectively, which is why profiling is used to decide where to spend it.

Profiling changes testing strategy as well as detection

Because deviations point to a period rather than a single event, they direct when the next tests should occur and whether they should be out of competition.

Stored samples can also be reanalysed later, so a profile that becomes suspicious over years can prompt a return to samples collected long before.

The deterrent works through uncertainty. An athlete cannot know which sample will be reanalysed or when a pattern will become statistically clear.